Finance

Lists
AVXL:NASDAQ
Anavex Life Sciences Corp
$1.64
-0.33%
(-0.0055) 1D
Oct 6, 10:43:59 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVXL...
Open
$1.66
High
$1.71
Low
$1.63
Mkt. cap
167.63M
Avg. vol.
999.06K
Volume
527.61K
52-wk high
$10.38
52-wk low
$1.63
EPS
-$0.15
Beta
1.17
Shares outstanding
92.70M
No. of employees
34
Open
$1.66
High
$1.71
Low
$1.63
Mkt. cap
167.63M
Avg. vol.
999.06K
Volume
527.61K
52-wk high
$10.38
52-wk low
$1.63
EPS
-$0.15
Beta
1.17
Shares outstanding
92.70M
No. of employees
34
News stories
From web sources and news partners
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteanavex.com
Analyst
Recommendation
Action
Price target
Projected
Date
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$20.00
+1,119.9%
05/04/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+1,119.9%
03/31/2026
Soumit Roy
JonesTrading
Hold
Maintained
-
-
11/14/2025
Last report
Aug 25, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.08 / -$0.08
+200.00%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.28M
4.62M
4.16M
-4.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.55M
2.13M
2.29M
-2.03M
Operating expense
10.83M
6.75M
6.46M
-6.77M
Total operating expenses
10.83M
6.75M
6.46M
-6.77M
Operating income
-10.83M
-6.75M
-6.46M
6.77M
Other non operating income
-
-
-
-
EBT including unusual items
-9.83M
-5.66M
-5.34M
7.82M
EBT excluding unusual items
-9.83M
-5.66M
-5.34M
7.82M
Income tax expense
-
18.00K
-
-
Effective tax rate
-
-0.32%
-
-
Other operating expenses
-
-
-
-
Net income
-9.83M
-5.68M
-5.34M
7.82M
Net profit margin
-
-
-
-
Earnings per share
-0.11
-0.06
-0.06
0.08
Interest and investment income
999.00K
1.08M
1.06M
1.07M
Interest expense
-
-
-
-
Net interest expenses
999.00K
1.08M
1.06M
1.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps